1680.60
-0.84%
Axis Direct
we maintain our HOLD rating with a target price of 1,760, implying an upside potential of ~9.4%, valuing the company at a PE of 26x for FY26.
Gland Pharma Ltd. has an average target of 2250.00 from 3 brokers.
More from Gland Pharma Ltd.
Recommended